Juvenal Tobin W: insider trades.
Juvenal Tobin W reported 10 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($1.3M), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 10
- Companies
- 1
- Name as filed
- Juvenal Tobin W
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Castle Biosciences Inc (CSTL) | Officer · Chief Commercial Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Castle Biosciences Inc | S | 3,294 | $35.14 | 58,584 | Form 4 |
| 2026-09-14 | Castle Biosciences Inc | S | 3,306 | $32.32 | 61,878 | Form 4 |
| 2026-08-31 | Castle Biosciences Inc | S | 1,730 | $32.81 | 65,184 | Form 4 |
| 2026-08-25 | Castle Biosciences Inc | S | 9,050 | $35.04 | 66,914 | Form 4 |
| 2026-08-17 | Castle Biosciences Inc | S | 1,730 | $29.59 | 75,964 | Form 4 |
| 2026-08-03 | Castle Biosciences Inc | S | 1,730 | $28.25 | 78,995 | Form 4 |
| 2026-07-31 | Castle Biosciences Inc | S | 1,891 | $30.26 | 80,725 | Form 4 |
| 2026-07-31 | Castle Biosciences Inc | S | 8,149 | $28.84 | 89,886 | Form 4 |
| 2026-07-31 | Castle Biosciences Inc | S | 7,270 | $29.58 | 82,616 | Form 4 |
| 2025-11-24 | Castle Biosciences Inc | S | 1,301 | $38.39 | 77,694 | Form 4 |
Questions
What stock did Juvenal Tobin W buy or sell?
Juvenal Tobin W reported 10 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($1.3M), across 1 company.
Is Juvenal Tobin W the same person as other filers with this name?
This page covers SEC CIK 1856542 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/juvenal-tobin-w-1856542.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.